Optura is a technology company.
Optura has raised $7.0M across 1 funding round.
Optura has raised $7.0M in total across 1 funding round.
Optura is an AI orchestration platform purpose-built for healthcare enterprises, particularly payers and health plans, designed to transition organizations from fragmented AI pilots to unified, governed, enterprise-scale deployments that deliver measurable ROI.[1][2][4] Its AIEOS (AI Enterprise Operating System) includes components like the Intent Engine for defining high-impact use cases, the Operator for deployment tracking and visibility, and the Librarian for continuous learning attuned to healthcare workflows, regulations, and goals, enabling rapid value capture such as tens of millions in cost savings within months.[2][4][5] Optura serves health plans and tech-enabled services, solving the "AI paralysis" of failed pilots by focusing on payer-specific KPIs like cost reduction, operational efficiency, and member experience improvements through HIPAA-compliant, ROI-tracked AI agents deployable in 30–90 days.[1][4][5]
The company emphasizes operator-led engineering over theoretical approaches, with prebuilt modules, C-suite dashboards, and pricing models like PMPM or per-claim to align with healthcare economics, distinguishing it from generic AI tools.[1][2]
Optura was founded in November 2024 by Andy Fanning, former VP of AI/Automation at Cigna, and Michael Hollis, former President and CGO of Emids, both healthcare operators with decades of experience alongside enterprise leaders.[1][2][5] The idea emerged from their firsthand frustration with "innovation theater"—disconnected AI pilots that fail to scale due to lacking governance, ROI proof, and payer alignment—prompting them to build a pragmatic platform for real operational impact.[2][4][5]
Early traction came swiftly: Susa Ventures invested in 2025, citing the founders' expertise in bridging AI to healthcare realities, followed by a $6.5M+ seed round and additional backing from HC9 Ventures in October 2025, fueling deployments that track savings, efficiencies, and revenue growth across workflows.[2][5] Both founders hold controlling interest in the Delaware-registered entities, Optura Inc. and Optura Holdings LLC.[5]
(Note: A separate, older Optura focused on SAP-centric business process optimization was acquired by Open Text Corp., unrelated to this AI healthcare startup.[3])
Optura stands out in the AI healthcare space through these key strengths:
Optura rides the AI adoption wave in the $5T U.S. healthcare market, where low tech penetration—still reliant on paper forms in 2025—meets exploding LLM potential, but stalls on scaling pilots amid regulatory and ROI hurdles.[2][4] Timing is critical as "enterprise paralysis" risks competitive lag; Optura acts as connective tissue, enabling payers to harness AI for cost cuts, better outcomes, and streamlined ops amid rising pressures like administrative burdens and value-based care.[1][2][5]
It influences the ecosystem by proving scalable AI governance, inspiring health plans to prioritize ROI-driven strategies over scattered experiments, and accelerating sector-wide shifts toward intelligent, harmonious systems that make care affordable—backed by top VCs like Susa, signaling validation for operator-led AI tools.[2][4][5]
Optura is primed for explosive growth as healthcare payers demand provable AI returns amid tightening margins and AI hype fatigue, with early wins like $50M+ savings positioning it for broader adoption across providers and services.[2][4] Expect expansions into new use cases via its dynamic value engine, more integrations with emerging LLMs, and potential Series A funding to scale globally, shaped by trends like payer consolidation and regulatory pushes for efficiency.[1][5]
As the antidote to failed pilots, Optura equips enterprises to finally deliver on AI's promise—lowering costs, enhancing care, and transforming healthcare's business model from the ground up.[1][2]
Optura has raised $7.0M in total across 1 funding round.
Optura's investors include Susa Ventures, Jason Lemkin, Nik Sharma.
Optura has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Seed in May 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2025 | $7.0M Seed | Susa Ventures, Jason Lemkin, Nik Sharma |